STIMULATION OF TYROSINASE IN HUMAN MELANOCYTES BY PRO-OPIOMELANOCORTIN-DERIVED PEPTIDES

被引:30
|
作者
MCLEOD, SD [1 ]
SMITH, C [1 ]
MASON, RS [1 ]
机构
[1] UNIV SYDNEY, DEPT PHYSIOL, SYDNEY, NSW 2006, AUSTRALIA
关键词
D O I
10.1677/joe.0.1460439
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human melanocytes, maintained on bovine corneal endothelium-derived extracellular matrix for at least 4 days in the absence of phorbol 12-myristate 13-acetate (PMA) and cholera toxin (CT), displayed increased tyrosinase activity when exposed to several pro-opiomelanocortin-derived (POMC) peptides. Melanocytes from 9 of 14 donors showed significantly increased tyrosinase activity after treatment with adrenocorticotropic hormone (ACTH; mean increase 320 +/- 107 (S.E.M.)% of control, P<0.005), while melanocytes from 8 of 13 donors increased tyrosinase in the presence of diacetyl-melanocyte stimulating hormone (di-MSH; mean increase 223 +/- 31 (S.E.M.)% Of control, P<0.005). Maximal increases in tyrosinase were seen after treatment with 10(-10) M ACTH and with 10(-6) M di-MSH. In two cell cultures which showed tyrosinase stimulation, melanin synthesis was similarly increased in the presence of added POMC peptides. PMA but not CT increased tyrosinase activity in melanocytes cultured under these conditions. In the presence of staurosporine, an inhibitor of protein kinase C (PKC), the magnitude of the increase in tyrosinase due to PMA, ACTH and di-MSH was significantly reduced. These results indicate that tyrosinase activity in melanocytes from most human donors, under appropriate conditions, is susceptible to the stimulatory effects of POMC peptides, that ACTH is considerably more potent than di-MSH in this test system and that in human cells the PKC pathway may be important in modulating melanogenesis.
引用
收藏
页码:439 / 447
页数:9
相关论文
共 50 条
  • [1] REGIONAL DISTRIBUTION OF PRO-OPIOMELANOCORTIN-DERIVED PEPTIDES IN THE HUMAN-BRAIN
    EMSON, PC
    CORDER, R
    RATTER, SJ
    TOMLIN, S
    LOWRY, PJ
    RESS, LH
    ARREGUI, A
    ROSSER, MN
    [J]. NEUROENDOCRINOLOGY, 1984, 38 (01) : 45 - 50
  • [2] Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes
    Mountjoy, Kathleen G.
    [J]. BIOCHEMICAL JOURNAL, 2010, 428 : 305 - 324
  • [3] THE ACTION OF PRO-OPIOMELANOCORTIN-DERIVED PEPTIDES ON TESTICULAR CELLS
    BARDIN, CW
    MORRIS, PL
    CHEN, CLC
    BOITANI, C
    KRIEGER, DT
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 512 : 308 - 317
  • [4] Expression and regulation of pro-opiomelanocortin-derived peptides in human hair growth and pigmentation
    Tobin, DJ
    [J]. EXPERIMENTAL DERMATOLOGY, 2004, 13 (09) : 569 - 569
  • [5] BIOSYNTHESIS OF PRO-OPIOMELANOCORTIN-DERIVED PEPTIDES IN THE MOUSE NEUROINTERMEDIATE LOBE
    JENKS, BG
    VANDAAL, JHHN
    SCHARENBERG, JGM
    MARTENS, GJM
    VANOVERBEEKE, AP
    [J]. JOURNAL OF ENDOCRINOLOGY, 1983, 98 (01) : 19 - 34
  • [6] IDENTIFICATION AND POSSIBLE FUNCTION OF PRO-OPIOMELANOCORTIN-DERIVED PEPTIDES IN THE TESTIS
    BARDIN, CW
    SHAHA, C
    MATHER, J
    SALOMON, Y
    MARGIORIS, AN
    LIOTTA, AS
    GERENDAI, I
    CHEN, CL
    KRIEGER, DT
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1984, 438 (DEC) : 346 - 364
  • [7] Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes
    Bhardwaj, RS
    Schwarz, A
    Becher, E
    Mahnke, K
    Aragane, Y
    Schwarz, T
    Luger, TA
    [J]. JOURNAL OF IMMUNOLOGY, 1996, 156 (07): : 2517 - 2521
  • [8] FEEDING-BEHAVIOR AND PRO-OPIOMELANOCORTIN-DERIVED PEPTIDES IN DUNGENESS CRABS
    COLASURDO, EA
    JORGENSEN, DD
    GALT, SA
    WILKINSON, CW
    [J]. AMERICAN ZOOLOGIST, 1991, 31 (05): : A19 - A19
  • [9] Effect of organophosphate administration on the expression of pro-opiomelanocortin-derived peptides in motoneurones
    Amos, ML
    Smith, ME
    [J]. NEUROTOXICOLOGY, 1998, 19 (06) : 789 - 797
  • [10] The effect of pyridostigmine administration on the expression of pro-opiomelanocortin-derived peptides in motoneurones
    Amos, ML
    Smith, ME
    [J]. NEUROTOXICOLOGY, 1998, 19 (06) : 799 - 807